Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **hemoglobin beta-globin gene locus** refers to a linear cluster of genes found on human chromosome 11, encoding the beta-like globin chains that are part of hemoglobin, the protein responsible for transporting oxygen in red blood cells[1][4]. This locus includes the embryonic (ε), fetal (Gγ and Aγ), and adult (δ and β) globin genes, each expressed at different stages of development according to tightly regulated mechanisms involving a locus control region (LCR) upstream from the cluster[1][3][5]. Genetic mutations or deletions within this locus underlie many hemoglobinopathies, such as beta-thalassemia and sickle cell disease[4][8]. The locus is critical for normal erythropoiesis and balancing the synthesis of alpha- and beta-globin chains required to form functional hemoglobin[4]. While individual hemoglobin subunits (such as the β chain) are direct therapeutic targets, the entire gene locus is a genomic region and not a classic molecular target like a receptor, enzyme, or transporter[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hemoglobin beta-globin gene locus (HBB locus).